This case study features a biopharmaceutical manufacturer determined to accelerate its timeline for delivering biosimilar mAbs to emerging markets. Help was needed to quickly convert existing stainless steel processes to single-use technologies, generate material for comparability and pre-clinical studies, and build a flexible mAb manufacturing facility in Asia. By working closely with Cytiva’s Fast Trak™ scientists and Cytiva global support staff, substantial time was saved compared to customer internal timelines.
Cytiva and the Drop logo are trademarks of Life Sciences IP Holdings Corporation or an affiliate doing business as Cytiva. Fast Trak is a trademark of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva. Any other third-party trademarks are the property of their respective owners. © 2021 Cytiva.